Clinical Trial Update: TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adding an anti-CD20 monoclonal antibody to thrombopoietin receptor agonists for pediatric immune thrombocytopenia, comparing combinatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)
• Eltrombopag (eltrombopag)
• Rituximab (rituximab)
• Romiplostim (romiplostim)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Primary Immune Thrombocytopenia (ITP) | Phase 4 | Status: UNKNOWN